Department of Pediatrics, University Medical Center Groningen, University of Groningen, the Netherlands.
Hepatology. 2013 Jul;58(1):293-303. doi: 10.1002/hep.26316. Epub 2013 May 14.
Biliary lipid secretion plays an important role in gallstone disease and reverse cholesterol transport (RCT). Using Sr-bI/Abcg5 double knockout mice (dko), the present study investigated the differential contribution of two of the most relevant transporters: adenosine triphosphate (ATP)-binding cassette subfamily G member 5 and 8 (ABCG5/G8) and scavenger receptor class B type I (SR-BI) to sterol metabolism and RCT. Plasma cholesterol levels increased in the following order, mainly due to differences in high density lipoprotein (HDL): Abcg5 ko < wild type < Sr-bI/Abcg5 dko < Sr-bI ko. Liver cholesterol content was elevated in Sr-bI ko only (P < 0.05). In Sr-bI/Abcg5 dko plasma plant sterols were highest, while hepatic plant sterols were lower compared with Abcg5 ko (P < 0.05). Under baseline conditions, biliary cholesterol secretion rates decreased in the following order: wild type > Sr-bI ko (-16%) > Abcg5 ko (-75%) > Sr-bI/Abcg5 dko (-94%), all at least P < 0.05, while biliary bile acid secretion did not differ between groups. However, under supraphysiological conditions, upon infusion with increasing amounts of the bile salt tauroursodeoxycholic acid, Abcg5 became fully rate-limiting for biliary cholesterol secretion. Additional in vivo macrophage-to-feces RCT studies demonstrated an almost 50% decrease in overall RCT in Sr-bI/Abcg5 dko compared with Abcg5 ko mice (P < 0.01).
These data demonstrate that (1) SR-BI contributes to ABCG5/G8-independent biliary cholesterol secretion under basal conditions; (2) biliary cholesterol mass secretion under maximal bile salt-stimulated conditions is fully dependent on ABCG5/G8; and (3) Sr-bI contributes to macrophage-to-feces RCT independent of Abcg5/g8.
胆汁脂质分泌在胆石病和胆固醇逆转运(RCT)中起着重要作用。本研究使用 Sr-bI/Abcg5 双敲除小鼠(dko),研究了两种最相关的转运蛋白:三磷酸腺苷(ATP)结合盒亚家族 G 成员 5 和 8(ABCG5/G8)和清道夫受体 B 类 I 型(SR-BI)对胆固醇代谢和 RCT 的差异贡献。血浆胆固醇水平的增加顺序主要是由于高密度脂蛋白(HDL)的差异:Abcg5 ko <野生型< Sr-bI/Abcg5 dko <Sr-bI ko。仅 Sr-bI ko 的肝胆固醇含量升高(P <0.05)。在 Sr-bI/Abcg5 dko 中,血浆植物固醇最高,而肝植物固醇比 Abcg5 ko 低(P <0.05)。在基础条件下,以下顺序胆汁胆固醇分泌率降低:野生型> Sr-bI ko(-16%)> Abcg5 ko(-75%)> Sr-bI/Abcg5 dko(-94%),均至少 P <0.05,而胆汁胆汁酸分泌在各组之间无差异。然而,在超生理条件下,随着胆汁盐牛磺熊脱氧胆酸输注量的增加,Abcg5 成为胆汁胆固醇分泌的完全限速因素。另外,体内巨噬细胞到粪便 RCT 研究表明,与 Abcg5 ko 小鼠相比,Sr-bI/Abcg5 dko 中的总 RCT 降低了近 50%(P <0.01)。
这些数据表明:(1)SR-BI 在基础条件下有助于 ABCG5/G8 独立的胆汁胆固醇分泌;(2)在最大胆汁盐刺激条件下的胆汁胆固醇质量分泌完全依赖于 ABCG5/G8;(3)Sr-bI 有助于巨噬细胞到粪便 RCT,独立于 Abcg5/g8。